Korean J Gastroenterol.  2010 Feb;55(2):85-93. 10.4166/kjg.2010.55.2.85.

Health-Related Quality of Life Issues in Gastroesophageal Reflux Disease

• Oh JH

• KMID: 1718291
• DOI: http://doi.org/10.4166/kjg.2010.55.2.85

Abstract

Several studies have reported significant Health-Related Quality of life (HRQOL) impairment in gastroesophageal reflux disease (GERD) patients compared with the general population. The evaluation of quality of life is important as a parameter for the treatment. Because GERD has diverse symptoms such as esophageal and extraesophageal syndromes, HRQOL of GERD should be determined by both disease and non-disease related factors. The purpose is to overview the HRQOL instruments used in the evaluation of GERD, published reports regarding HRQOL in GERD, and the effects of medical treatments on GERD.

Keyword

Gastroesophageal reflux disease; Quality of life

MeSH Terms

Gastroesophageal Reflux/diagnosis/*psychology/therapy
Health Status
Humans
*Quality of Life
Questionnaires

Reference

1. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med. 1996; 334:835–840.

2. Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K. Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008; 27:1053–1070.

3. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003; 18:595–604.

4. Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci. 2008; 53:188–193.

5. Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004; 19(suppl):S22–S25.

6. Kim JI, Kim SG, Kim N, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol. 2009; 21:787–793.

7. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004; 53(suppl):iv1–24.

8. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920.

9. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008; 23:8–22.

10. Fujiwara Y, Takahashi S, Arakawa T, et al. A 2008 questionnaire-based survey of gastroesophageal reflux disease and related diseases by physicians in East asian countries. Digestion. 2009; 80:119–128.

11. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease – an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003; 18:767–776.

12. Bruley Des Varannes S, Marek L, Humeau B, Lecasble M, Colin R. Gastroesophageal reflux disease in primary care. Prevalence, epidemiology and Quality of Life of patients. Gastroenterol Clin Biol. 2006; 30:364–370.

13. Hongo M, Kinoshita Y, Shimozuma K, Kumagai Y, Sawada M, Nii M. Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn. J Gastroenterol. 2007; 42:807–815.

14. Sjoland H, Wiklund I, Caidahl K, Haglid M, Westberg S, Herlitz J. Improvement in quality of life and exercise ca-pacity after coronary bypass surgery. Arch Intern Med. 1996; 156:265–271.

15. Dimenas E. Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases. Scand J Gastroenterol. 1993; 199(suppl):S18–S21.

16. Irvine EJ. Measuring quality of life: a review. Scand J Gastroenterol. 1996; 31(suppl):S5–S7.

17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473–483.

18. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. Wender NK, Mattson ME, Furberg CD, Elinson J, editors. eds.Assessment of quality of life in clinical trials of cardiovascular therapies. Boston, MA: Le JACQ;1984. p. 170–183.

19. EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990; 16:199–208.

20. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric proper-ties. Soc Sci Med. 1998; 46:1569–1585.

21. Development of the World Health Organization WHOQOL- BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998; 28:551–558.

22. Min SK, Lee CI, Kim KI, Suh SY, Kim DK. Deveolpment of Korean version of WHO quality of life scale abbreviated version (WHOQOL-BREF). J Korean Neuropsychiatr Assoc. 2000; 39:571–579.

23. Oh JH, Kim TS, Choi MG, et al. Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Gut Liver. 2009; 3:259–265.

24. Park YR, Kim TS, Park YG, et al. Influence of multiple insulin injections on quality of life, anxiety levels, and depression in type 2 diabetics. Korean J Med. 2009; 77:60–67.

25. Mathias SD, Colwell HH, Miller DP, Pasta DJ, Henning JM, Ofman JJ. Health-Related quality-of-life and quality-days in-crementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine. Dig Dis Sci. 2001; 46:2416–2423.

26. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999; 231(suppl):S20–S28.

27. Wiklund IK, Junghard O, Grace E, et al. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg. 1998; 583(suppl):S41–S49.

28. de la Loge C, Trudeau E, Marquis P, et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004; 13:1751–1762.

29. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995; 82:216–222.

30. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996; 183:217–224.

31. Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J. 1996; 30:185–193.

32. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastroesophageal reflux disease (WPAI-GERD)–results from a cross-sectional study. Value Health. 2002; 5:106–113.

33. Brozek JL, Guyatt GH, Heels-Ansdell D, et al. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol. 2009; 62:102–110.

34. Irvine EJ. Quality of life assessment in gastro-oesophageal reflux disease. Gut. 2004; 53(suppl):iv35–39.

35. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994; 69:539–547.

36. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci. 2001; 46:1540–1549.

37. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A. Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci. 2002; 47:1530–1537.

38. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001; 96(suppl):S57–S61.

39. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003; 17:1309–1317.

40. Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population–the Kalixanda study. Aliment Pharmacol Ther. 2006; 23:1725–1733.

41. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol. 2006; 101:18–28.

42. Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA. Relationship between symptom load of gas-tro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther. 2008; 27:960–970.

43. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009; 43:111–117.

44. Nocon M, Labenz J, Jaspersen D, et al. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther. 2009; 29:662–668.

45. Ponce J, Beltran B, Ponce M, et al. Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: the relevance of the biometric factors and the severity of symptoms. Eur J Gastroenterol Hepatol. 2009; 21:620–629.

46. Hansen JM, Wildner-Christensen M, Schaffalitzky de Muckadell OB. Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and healthcare use. Am J Gastroenterol. 2009; 104:2394–2403.

47. Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther. 2007; 25:1451–1459.

48. Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes. 2009; 7:60.

49. Yang SY, Lee OY, Kim HE, et al. Dietary related risk factors and quality of life in patients with gastroesophageal reflux disease. Korean J Med. 2006; 70:627–635.

50. Jeong JJ, Choi MG, Cho YS, et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol. 2008; 14:6388–6394.

51. Stanghellini V, Armstrong D, Monnikes H, Bardhan KD. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther. 2004; 19:463–479.

52. Quigley EM, Hungin AP. Review article: quality-of-life issues in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005; 22(suppl):S41–S47.

53. Lippmann QK, Crockett SD, Dellon ES, Shaheen NJ. Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease. Am J Gastroenterol. 2009; 104:2695–2703.

54. Shaker R, Brunton S, Elfant A, Golopol L, Ruoff G, Stanghellini V. Review article: impact of nighttime reflux on lifestyle - unrecognized issues in reflux disease. Aliment Pharmacol Ther. 2004; 20(suppl):S3–S13.

55. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001; 161:45–52.

56. Fass R. Distinct phenotypic presentations of gastroesophageal reflux disease: a new view of the natural history. Dig Dis. 2004; 22:100–107.

57. Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007; 5:690–695.

58. Tack J, Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther. 2004; 19(suppl):S28–S34.

59. Kovacs Z, Kerekgyarto O. Psychological factors, quality of life, and gastrointestinal symptoms in patients with erosive and non-erosive reflux disorder. Int J Psychiatry Med. 2007; 37:139–150.

60. Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol. 2000; 95:1881–1887.

61. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998; 104:252–258.

62. Revicki DA, Sorensen S, Maton PN, Orlando RC. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis. 1998; 16:284–291.

63. Velanovich V. Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review. Eur J Surg. 2000; 166:516–525.

64. Kaplan-Machlis B, Spiegler GE, Zodet MW, Revicki DA. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia. Arch Fam Med. 2000; 9:624–630.

65. Kaspari S, Biedermann A, Mey J. Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion. 2001; 63:163–170.

66. Johanson JF, Siddique R, Damiano AM, Jokubaitis L, Murthy A, Bhattacharjya A. Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. Dig Dis Sci. 2002; 47:2574–2578.

67. Pare P, Armstrong D, Pericak D, Pyzyk M. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. J Clin Gastroenterol. 2003; 37:132–138.

68. Ponce J, Arguello L, Bastida G, Ponce M, Ortiz V, Garrigues V. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Dig Dis Sci. 2004; 49:931–936.

69. Pace F, Negrini C, Wiklund I, Rossi C, Savarino V; Italian One Investigators Study Group. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gas-tro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005; 22:349–356.

70. de Souza Cury M, Ferrari AP, Ciconelli R, Ferraz MB, Moraes-Filho JP. Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole. Dis Esophagus. 2006; 19:289–293.

71. Hansen AN, Bergheim R, Fagertun H, Lund H, Wiklund I, Moum B. Longterm management of patients with symptoms of gastro-oesophageal reflux disease – a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting. Int J Clin Pract. 2006; 60:15–22.

72. Hongo M, Kinoshita Y, Miwa H, Ashida K. The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. J Gastroenterol. 2008; 43:920–927.

73. Kinoshita Y, Ashida K, Miwa H, Hongo M. The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor. Am J Gastroenterol. 2009; 104:1106–1111.